ALC:NYE-Alcon AG (USD)

COMMON STOCK | Medical Instruments & Supplies |

Last Closing

USD 94.68

Change

+0.98 (+1.05)%

Market Cap

USD 44.32B

Volume

1.44M

Analyst Target

USD 65.36
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. It operates through two segments, Surgical and Vision Care. The company offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, grieshaber, MIVS instruments, scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-24 )

Largest Industry Peers for Medical Instruments & Supplies

Symbol Name Price(Change) Market Cap
BDX Becton Dickinson and Company

+2.13 (+1.05%)

USD 57.94B
RMD ResMed Inc

+21.66 (+10.10%)

USD 31.43B
BAX Baxter International Inc

+0.81 (+2.74%)

USD 14.28B
SOLV Solventum Corp.

+1.63 (+2.47%)

USD 11.45B
AVTR Avantor Inc

+0.03 (+0.19%)

USD 10.37B
ATR AptarGroup Inc

+3.41 (+2.30%)

USD 9.51B
STVN Stevanato Group SpA

+0.08 (+0.37%)

USD 5.98B
TFX Teleflex Incorporated

+2.64 (+1.98%)

USD 5.79B
BLCO Bausch + Lomb Corp

+1.15 (+9.03%)

USD 4.29B
WRBY Warby Parker Inc

+0.92 (+6.17%)

USD 1.79B

ETFs Containing ALC

CHSR:XETRA UBS(Lux)Fund Solutions .. 5.04 % 0.00 %

+0.14 (+0.86%)

USD 0.17B
CHSRI:SW UBS ETF (CH) - MSCI Switz.. 5.01 % 0.00 %

+0.17 (+0.86%)

N/A
CHSRIA:SW UBS ETF (CH) MSCI Switzer.. 5.01 % 0.00 %

+0.26 (+0.86%)

N/A
CHSRII:SW UBS(Lux)Fund Solutions .. 4.98 % 0.00 %

+0.10 (+0.86%)

N/A
SLICHA:SW UBS ETF (CH) – SLI® (C.. 4.71 % 0.00 %

N/A

USD 32,912.73B
DXS0:XETRA Xtrackers SLI UCITS ETF 1.. 4.71 % 0.00 %

+2.05 (+0.86%)

USD 0.26B
XSLI:SW Xtrackers SLI UCITS ETF 1.. 4.71 % 0.00 %

+1.65 (+0.86%)

USD 0.31B
CSSLI:SW iShares SLI® ETF (CH) 4.68 % 0.00 %

+2.50 (+0.86%)

USD 0.67B
EXI1:XETRA iShares SLI UCITS ETF (DE.. 4.66 % 0.00 %

+1.36 (+0.86%)

USD 0.37B
SMIEX:SW iShares SLI UCITS ETF (DE.. 4.32 % 0.00 %

+1.30 (+0.86%)

USD 5,933.96B
CBCH30:SW 3.78 % 0.00 %

N/A

N/A
C030:XETRA Amundi Index Solutions - .. 3.57 % 0.00 %

+2.10 (+0.86%)

USD 0.13B
DXSE:XETRA Xtrackers - Stoxx Europe .. 3.26 % 0.00 %

+0.70 (+0.86%)

USD 0.14B
XSMC:SW Xtrackers Switzerland UCI.. 3.15 % 0.00 %

+1.36 (+0.86%)

USD 0.52B
XSMI:SW Xtrackers Switzerland UCI.. 3.15 % 0.00 %

+1.38 (+0.86%)

USD 1.36B
XSMI:XETRA Xtrackers Switzerland UCI.. 3.15 % 0.00 %

+1.12 (+0.86%)

N/A
SMICHA:SW UBS ETF (CH) – SMI® (C.. 3.15 % 0.00 %

+1.18 (+0.86%)

USD 17,142.72B
CSSMI:SW iShares SMI® ETF (CH) 3.13 % 0.00 %

+1.18 (+0.86%)

USD 2.18B
ESRU:LSE Amundi Index Solutions - .. 3.12 % 0.00 %

+0.27 (+0.86%)

N/A
ACU7:XETRA Amundi Index Solutions - .. 3.10 % 0.00 %

+0.29 (+0.86%)

USD 0.13B
ESDU:LSE Amundi Index Solutions - .. 3.09 % 0.00 %

+0.24 (+0.86%)

N/A
ESIH:LSE iShares MSCI Europe Healt.. 2.87 % 0.00 %

+0.04 (+0.86%)

USD 0.79B
SWUSAH:SW UBS ETF (CH) – MSCI Swi.. 2.82 % 0.00 %

+0.24 (+0.86%)

USD 226,274.21B
STW:PA SPDR® MSCI Europe Health.. 2.80 % 0.00 %

+2.12 (+0.86%)

USD 0.66B
EUSRI:PA Amundi Index Solutions - .. 2.79 % 0.00 %

+0.39 (+0.86%)

USD 1.89B
CHEUR:SW UBS(Lux)Fund Solutions .. 2.79 % 0.00 %

N/A

N/A
CHEURD:SW UBS(Lux)Fund Solutions .. 2.79 % 0.00 %

N/A

N/A
CHUSD:SW UBS(Lux)Fund Solutions .. 2.79 % 0.00 %

+0.11 (+0.86%)

N/A
CHUSDD:SW UBS(Lux)Fund Solutions .. 2.79 % 0.00 %

N/A

N/A
SWICHA:SW UBS ETF (CH) – MSCI Swi.. 2.77 % 0.00 %

+0.24 (+0.86%)

USD 226,274.25B
SW2CHA:SW UBS(Lux)Fund Solutions .. 2.76 % 0.00 %

+0.28 (+0.86%)

USD 0.51B
SW2CHB:SW UBS(Lux)Fund Solutions .. 2.76 % 0.00 %

+0.29 (+0.86%)

USD 1.78B
SW2UKD:SW UBS(Lux)Fund Solutions .. 2.76 % 0.00 %

+0.19 (+0.86%)

USD 0.05B
SWEUAH:SW UBS ETF (CH) – MSCI Swi.. 2.70 % 0.00 %

N/A

USD 226,274.20B
EXV4:XETRA iShares STOXX Europe 600 .. 2.70 % 0.00 %

+0.88 (+0.86%)

USD 0.70B
S2HGBD:SW UBS(Lux)Fund Solutions .. 2.68 % 0.00 %

N/A

USD 0.07B
S2HGBA:SW UBS(Lux)Fund Solutions .. 2.68 % 0.00 %

N/A

USD 8.29M
STWX:SW SPDR® MSCI Europe Health.. 2.62 % 0.00 %

+2.70 (+0.86%)

USD 0.66B
ESRG:LSE Amundi Index Solutions - .. 2.60 % 0.00 %

N/A

USD 2.03B
ESDG:LSE Amundi Index Solutions - .. 2.60 % 0.00 %

+8.00 (+0.86%)

USD 0.19B
SXDPEX:SW iShares STOXX Europe 600 .. 2.54 % 0.00 %

N/A

USD 0.44B
SPICHA:SW UBS ETF (CH) – SPI® (C.. 2.53 % 0.00 %

+0.82 (+0.86%)

USD 131,872.43B
HEAE:LSE SPDR® MSCI Europe Health.. 2.50 % 0.00 %

+1.22 (+0.86%)

N/A
MEDTE:PA BNP Paribas Easy ECPI Glo.. 2.29 % 0.00 %

+0.28 (+0.86%)

N/A
ASRP:XETRA BNP Paribas Easy ECPI Glo.. 2.26 % 0.00 %

+0.04 (+0.86%)

N/A
MTUSD:PA BNP Paribas Easy ECPI Glo.. 2.16 % 0.00 %

N/A

N/A
EVOE:PA BNP Paribas Easy ESG Equi.. 2.09 % 0.00 %

+1.08 (+0.86%)

USD 0.05B
VLED:PA BNP Paribas Easy ESG Equi.. 2.09 % 0.00 %

-3.94 (0.86%)

USD 5.65M
VLED:SW 2.07 % 0.00 %

N/A

N/A
EWL iShares MSCI Switzerland .. 0.00 % 0.47 %

+0.73 (+0.86%)

N/A
LNGR 0.00 % 0.50 %

N/A

N/A
RNDM 0.00 % 0.65 %

N/A

N/A
FLSW Franklin FTSE Switzerland.. 0.00 % 0.09 %

+0.52 (+0.86%)

USD 0.05B
HLTH:LSE SPDR® MSCI Europe Health.. 0.00 % 0.00 %

+1.94 (+0.86%)

N/A
XSDR:LSE Xtrackers MSCI Europe Hea.. 0.00 % 0.00 %

+156.00 (+0.86%)

USD 0.21B
UC93:LSE UBS MSCI Switzerland 20/3.. 0.00 % 0.00 %

+30.25 (+0.86%)

USD 8.25M
UC94:LSE UBS(Lux)Fund Solutions .. 0.00 % 0.00 %

+24.75 (+0.86%)

USD 0.07B
C030:F Lyxor DJ Switzerland Tita.. 0.00 % 0.00 %

N/A

USD 0.01B
DBXS:F 0.00 % 0.00 %

N/A

N/A
DXS0:F Xtrackers - SLI UCITS ETF 0.00 % 0.00 %

+1.65 (+0.86%)

N/A
DXSE:F Xtrackers Stoxx Europe 60.. 0.00 % 0.00 %

+2.95 (+0.86%)

N/A
EL4X:F Deka DAXplus Maximum Divi.. 0.00 % 0.00 %

+0.74 (+0.86%)

N/A
EXI1:F iShares SLI UCITS ETF (DE.. 0.00 % 0.00 %

+1.24 (+0.86%)

N/A
EXV4:F 0.00 % 0.00 %

N/A

N/A
EXV5:F 0.00 % 0.00 %

N/A

N/A
MIVB:F Amundi Index Solutions - .. 0.00 % 0.00 %

+0.32 (+0.86%)

N/A
SPYH:F SSgA SPDR ETFs Europe II .. 0.00 % 0.00 %

N/A

N/A
V3ET:F VanEck Vectors ETFs N.V. .. 0.00 % 0.00 %

N/A

USD 0.05B
VLED:F BNP Paribas Easy - Equity.. 0.00 % 0.00 %

-4.64 (0.86%)

USD 0.07B
VLEU:F BNP Paribas Easy - Equity.. 0.00 % 0.00 %

+5.28 (+0.86%)

USD 0.05B
DBXS:XETRA Xtrackers - Switzerland U.. 0.00 % 0.00 %

+1.12 (+0.86%)

USD 1.34B
MIVB:XETRA Amundi Index Solutions - .. 0.00 % 0.00 %

+0.43 (+0.86%)

N/A
SPYH:XETRA SPDR® MSCI Europe Health.. 0.00 % 0.00 %

+2.04 (+0.86%)

N/A
1391:TSE 0.00 % 0.00 %

N/A

N/A
CHSPI:SW iShares Core SPI® ETF (C.. 0.00 % 0.00 %

+1.32 (+0.86%)

USD 4.04B
CEFA Global X S&P Catholic Val.. 0.00 % 0.00 %

+0.41 (+0.86%)

USD 0.02B
AGNG Global X Aging Population.. 0.00 % 0.00 %

+0.50 (+0.86%)

USD 0.05B
ESIH:F Ishares VI PLC - Ishares .. 0.00 % 0.00 %

+0.09 (+0.86%)

N/A
ESIH:XETRA iShares MSCI Europe Healt.. 0.00 % 0.00 %

+0.04 (+0.86%)

N/A
CHDIV:SW UBS ETF (CH) - MSCI Switz.. 0.00 % 0.00 %

N/A

USD 1,244,681.59B

Market Performance

  Market Performance vs. Industry/Classification (Medical Instruments & Supplies) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 11.53% 100% F 91% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.53% 100% F 91% A-
Trailing 12 Months  
Capital Gain 20.09% 84% B 87% B+
Dividend Return 0.33% 33% F 4% F
Total Return 20.43% 84% B 86% B+
Trailing 5 Years  
Capital Gain 79.90% 93% A 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 79.90% 93% A 59% D-
Average Annual (5 Year Horizon)  
Capital Gain 10.62% 89% A- 70% C-
Dividend Return 10.89% 89% A- 64% D
Total Return 0.28% 33% F 8% B-
Risk Return Profile  
Volatility (Standard Deviation) 16.43% 84% B 61% D-
Risk Adjusted Return 66.32% 100% F 78% C+
Market Capitalization 44.32B 93% A 95% A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.